Makes sugar, distillery alcohol (ethanol), consumer products, co-generation power and nutraceuticals, with consolidated operations spanning crop nutrients and crop protection through subsidiary Coromandel International. In the standalone business for the period ended March 31, 2026, sugar contributed 45.1% of segment revenue (Rs 1,569.5 cr), distillery 33.1% (Rs 1,151.37 cr), consumer products 17.4% (Rs 607.15 cr), co-generation 3.5% (Rs 121.68 cr) and nutraceuticals 0.9% (Rs 32.59 cr). Consolidated FY26 revenue was Rs 38,534.08 crore, including Coromandel's nutrient and allied business (Rs 27,726.87 cr) and crop protection (Rs 3,968.25 cr). The company achieved 20% ethanol blending and expanded ethanol capacity. Operations span 9 Indian states and 20 countries, with a workforce of 4,116. It closed subsidiary PSRIPL's sugar refinery on March 31, 2026 due to sustained losses. Materials account for 59.6% of revenue. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Sugar (45%), Distillery (33%), Consumer products (17%), Co-generation (4%), Nutraceuticals (1%). Cyclical, commodity-exposed sugar and ethanol producer with consolidated agribusiness through Coromandel International
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 23,528 | 35,244 | 29,413 | 31,609 | 38,534 |
| EBITDA (ex other income) | 2,398 | 3,238 | 2,616 | 3,034 | 2,971 |
| margin % | 10.2 | 9.2 | 8.9 | 9.6 | 7.7 |
| Owners' profit | 907 | 947 | 900 | 878 | 570 |
| EPS, as reported (₹) | 51.17 | 53.39 | 50.68 | 49.47 | 32.03 |
| ROE % · ROCE % | 19.4 · 25.8 | 19.2 · 28.1 | 14.4 · 20.5 | 13.7 · 20.6 | 9.3 · 15.9 |
| Debt / equity (x) | 0.10 | 0.12 | 0.11 | 0.16 | 0.19 |
| Cash from operations | 2,278 | 359 | 1,972 | 1,936 | 1,542 |
| Capex | (449) | (860) | (975) | (1,046) | (1,617) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9,330 | 8,720 | 6,811 | 8,724 | 11,624 | 10,316 | 7,882 | 9,018 |
| Profit before tax | 824 | 590 | 751 | 616 | 1,062 | 588 | (162) | 423 |
| Net profit | 592 | 416 | 539 | 464 | 766 | 437 | (287) | 312 |
| EPS (₹) | 17.22 | 10.97 | 16.14 | 13.85 | 23.87 | 13.05 | (18.74) | 7.96 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| a. Nutrient and allied business | 4,953 | 12.6 |
| b. Crop protection | 1,076 | 2.7 |
| c. Sugar | 1,473 | 3.8 |
| d. Co-generation | 66 | 0.2 |
| e. Distillery | 275 | 0.7 |
| f. Nutraceuticals | 50 | 0.1 |
| g. Consumer products | 115 | 0.3 |
| Nutrient and allied business | 22,774 | 58.2 |
| Crop protection | 2,892 | 7.4 |
| Sugar | 3,893 | 9.9 |
| Co-generation | 56 | 0.1 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 10 Sept 2026 · SBI Mutual Fund raises stake in EID Parry to 9.14 percent | ownership changes | high | — | — |
| 25 Aug 2026 · CRISIL assigns ESG rating of 61 (Strong) to EID Parry for FY26 | business updates | medium | — | — |
| 19 Aug 2026 · EID Parry Q1 FY27 earnings call transcript filed with exchanges | investor communications | medium | — | — |
| 18 Aug 2026 · Newspaper notice on special window for physical share transfer re-lodgement | compliance | minimal | — | — |
| 14 Aug 2026 · EID Parry 51st AGM: All 5 resolutions passed; asset disposal gets 77.7% support | compliance | low | — | — |
| 13 Aug 2026 · Audio Recording Link for Q1 FY27 Conference Call | investor communications | medium | — | — |
| 13 Aug 2026 · Newspaper publication of Q1 FY27 unaudited financial results | compliance | minimal | — | — |
| 12 Aug 2026 · Q1 FY27 Results: Standalone Loss Widens to Rs 89 Crore | results | high | — | — |
| 12 Aug 2026 · Q1 FY27 results: Standalone loss widens to Rs 89 crore; consolidated profit at Rs 312 crore | results | high | — | — |
| 4 Aug 2026 · Independent Director Dr. Rea Godbole retires after completing two terms | management changes | medium | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| Distillery | 877 | 2.2 |
| Nutraceuticals | 150 | 0.4 |
| Consumer products | 504 | 1.3 |
| Total, before eliminations | 39,153 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| EID PARRY INDIA LTD ◆ | 12,861 | 27.7 | 0.86 | 4.4 | 9.3 | 13.1 | 15.7 | 8.7 |
| MANORAMA INDUSTRIES LTD | 12,300 | 47.9 | 18.03 | 34.0 | 33.0 | 42.4 | — | 30.3 |
| ORKLA INDIA LIMITED | 8,048 | 27.3 | 2.93 | 18.1 | 10.4 | 13.1 | — | 19.9 |
| KRISHIVAL FOODS LIMITED | 963 | 40.6 | 4.82 | 24.9 | 11.1 | 13.1 | — | 13.0 |
| APIS INDIA LTD. | 716 | 2.8 | 3.60 | 18.7 | 12.7 | 15.5 | 7.4 | 11.9 |
| Pajson Agro India Limited | 502 | 38.6 | — | — | — | 24.0 | — | — |
| MEGASTAR FOODS LIMITED | 311 | 31.5 | 3.02 | 12.3 | 9.0 | 7.5 | 26.4 | 5.8 |
| Wardwizard Foods and Beverages | 237 | 40.1 | 2.91 | — | 1.6 | 0.6 | — | 13.2 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 27.7 | 17.9 | 19 of 28 | 33% |
| P/B | 0.9 | 1.8 | 3 of 19 | 89% |
| ROCE | 13.1 | 12.1 | 13 of 31 | 60% |
| ROE | 9.3 | 5.1 | 9 of 23 | 64% |
| Debt / Equity | 0.2 | 0.4 | 9 of 23 | 64% |
| EBITDA margin | 8.7 | 8.7 | 11 of 21 | 50% |
| Revenue growth | 3.4 | 8.6 | 11 of 17 | 38% |
| Profit growth | (32.9) | 32.7 | 17 of 20 | 16% |
| Market cap | 12861 | 118 | 1 of 29 | 100% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
